Part 8/13:
Traditionally, vaccine development spans 10 to 15 years, but the urgent global need has compelled scientists to compress this timeline drastically—aiming for completion within 12 to 18 months. By running phases concurrently and leveraging advanced technologies, researchers strive to deliver safe and effective vaccines swiftly without compromising standards.
Singapore and other nations have adopted this accelerated approach, conducting early-phase clinical trials with volunteers, often combining phases to save time. This rapid pace is driven by the devastating economic and human toll of the pandemic, which demands urgent solutions.